This study is the first to illustrate the involvement of the rhythm gene NFIL3 in SA-AKI and demonstrated that NFIL3 inhibition alleviates SA-AKI by suppressing ACSL4-regulated ferroptosis and inflammation, which may provide a new therapeutic strategy for SA-AKI. The gene discussed is NFIL3; the disease is acute kidney injury.